Protein reagent 0872041-CF
antibodyfor researchcoronavirus

protein reagent
protein reagent
Add to favorites
Compare this product
 

Characteristics

Type
antibody
Applications
for research
Tested parameter
protein
Micro-organism
SARS-COV-2, coronavirus

Description

The 2019 Novel Coronavirus (SARS-CoV-2) is a coronavirus identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Its genome encodes four structural proteins, i.e. spike (S), envelope (E), membrane (M) and nucleocapsid (N). The spike protein (S-protein) contains two subunits, S1 and S2. S1 defines the range of the hosts and specificity of the virus, thus recognizes and binds with the cell surface receptor. S2 subunit contains basic elements needed for the membrane fusion. The spike protein is the common target for neutralizing antibodies and vaccines. Application Notes Western blot, FACS analysis, Virus neutralization Usage Statement Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. Application Notes - Western blot, FACS analysis, Virus neutralization Conjugate - Unconjugated Host - Mouse Isotype - IgG1 Specificity - Recognize coronavirus spike S2 Storage - Stable for twelve months from date of receipt when stored at -20 °C. Avoid repeated freeze-thaw cycles. Usage Statement - Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Catalogs

No catalogs are available for this product.

See all of MP Biomedicals‘s catalogs

Other MP Biomedicals products

Infectious Disease

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.